Octotarget is a medical journal published on a weekly basis addressing issues on the field of oncology. The journal is published by impact journals and is both open to all for free and is peer reviewed. The term peer reviewed indicates that the contents contained in the journal are subjected to scrutiny by scholars and practitioners in the field of oncology and proven to be factually and pragmatically accurate. The chief editors for Octotarget are Mikhail Blagosklonny and Andrei V. Gudkov of Roswell Park Cancer Institute.
Oncology is an area of the medical field that concerns itself with the prevention treatment of cancer after diagnosis. This field brings together the three components which have been identified as the most important in enhancing survival for cancer patients. These are prevention, early diagnosis, and proper treatment. This would involve such steps as avoiding such potent causes for cancer such as tobacco and alcohol, taking a regular screening for common cancers and pursuing a multimodal treatment method once one has been diagnosed with the disease.
Octotarget’s editor in chief Mikhail Blagosklonny believes passionately that the cancer treatment drug rapamycin could be quite useful in enhancing life extension as well as it has been effective in cancer treatment. Mr. Mikhail Blagosklonny studies cancer and aging and previously served as an oncology professor at the Roswell Park Cancer Center. He earned a masters’ degree in internal medicine and a Ph.D. in experimental medicine cardiology, both from the First Pavlov State Medical University of St. Peterburg. He served as an associate professor at the New York Medical College and later as a senior scientist at Ordway Research Institute at Albany in New York. He would then be appointed to the position of Oncology Professor at the Roswell Park Cancer Institute in 2009, just before the founding of the Octotarget Journal in 2010 in the following: https://www.facebook.com/Oncotarget/ click here.
Octotarget mainly concerns itself with propelling oncological ideas which posit a natural based approach to cancer prevention and treatment. Mr. Blagosklonny believes that the right treatment of cancer would also serve as the right anti-aging treatment, and this message is reflected in the journal.